MedTrace Logo

Pilot Study to Evaluate The Effectiveness And Safety Of Axiom Worldwide Drx9000™ Spinal Decompression System

NCT00414596 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-06-06

Study results available
· View outcomes & findings →

Summary

This pilot study will evaluate the effectiveness and safety of the Axiom Worldwide DRX9000 for active treatment of chronic low back pain.

Conditions

  • Low Back Pain

Interventions

DEVICE

DRX9000™

Device is designed to apply spinal decompressive forces.

Sponsors & Collaborators

  • NEMA Research, Inc.

    lead INDUSTRY

Principal Investigators

  • John Leslie, MD · Mayo Clinic

  • Charlotte Richmond, PhD · NEMA Research, Inc.

  • Joseph V Pergolizzi, MD · Naples Anesthesia and Pain Associates

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00414596 on ClinicalTrials.gov